Filing Flows

Filing Flows › Exelixis (EXEL) › Q3 2026 › vs Q2 2026

Exelixis (EXEL) Q3 2026 vs Q2 2026 (quarter over quarter)

Exelixis's revenue rose $30.0M (+5%) from $629M in Q2 2026 to $659M in Q3 2026. The biggest changes: Net product revenues +$31.9M (+6%); Collaboration −$1.9M (-3%); COMETRIQ −$607K (-26%). Operating margin 40.8% against 39.5% (+1.2 pts).

Exelixis, Q3 2026: revenue $659M (+10% year over year), operating margin 40.8%, net earnings $218M, operating cash flow $280M. The chart draws each line against Q2 2026, the increases inside each band.

Exelixis: what changed, Q3 2026 vs Q2 2026Exelixis: what changed, Q3 2026 vs Q2 2026Net product revenues$31.9MWorking capital & other−$29.9MOperating cash flow−$27.8MFree cash flow (OCF − capex)−$23.5MPre-tax earnings$20.1MOperating profit$20.0MIncome tax$14.1MCosts & expenses$10.0MSG&A$6.9MNet earnings$6.0M

Margins

Q3 2026Q2 2026Change
Operating margin40.8%39.5%+1.2 pts
Net margin33.1%33.7%-0.6 pts
Free cash flow margin42.1%47.9%-5.7 pts

Every line

LineQ3 2026Q2 2026Change%
Net product revenues$605M$573M$31.9M+6%
Collaboration$53.8M$55.7M−$1.9M-3%
COMETRIQ$1.8M$2.4M−$607K-26%
Revenue$659M$629M$30.0M+5%
Other income, net$14.4M$14.3M$98K+0.7%
Operating profit$268M$248M$20.0M+8%
Costs & expenses$390M$380M$10.0M+3%
Pre-tax earnings$283M$263M$20.1M+8%
Cost of revenue$26.2M$20.7M$5.6M+27%
Research & development$209M$212M−$2.5M-1%
SG&A$155M$148M$6.9M+5%
Net earnings$218M$212M$6.0M+3%
Income tax$64.7M$50.6M$14.1M+28%
Depreciation & amortization$6.9M$7.0M−$49K-0.7%
Share-based compensation$28.7M$32.6M−$3.8M-12%
Working capital & other$26.2M$56.1M−$29.9M-53%
Operating cash flow$280M$308M−$27.8M-9%
Free cash flow (OCF − capex)$277M$301M−$23.5M-8%
Capital expenditures$2.5M$6.8M−$4.3M-63%

Questions

How much did Exelixis's revenue grow quarter over quarter in Q3 2026?

Exelixis's revenue rose $30.0M (+5%) from $629M in Q2 2026 to $659M in Q3 2026.

What drove Exelixis's revenue change in Q3 2026?

Net product revenues +$31.9M (+6%); Collaboration −$1.9M (-3%); COMETRIQ −$607K (-26%).

Q3 2026 results → · Compare in the interactive Sankey →